RECURRENT MYELOPROLIFERATIVE NEOPLASM
Clinical trials for RECURRENT MYELOPROLIFERATIVE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MYELOPROLIFERATIVE NEOPLASM trials appear
Sign up with your email to follow new studies for RECURRENT MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial targets genetic flaws in blood cancers
Disease control Recruiting nowThis study is testing a combination of two drugs, azacitidine and quizartinib, for adults with specific types of bone marrow and blood cancers (MDS and MDS/MPN). The goal is to find the safest and most effective dose and to see how well the combination controls the disease in pat…
Matched conditions: RECURRENT MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new combination of two drugs, axatilimab and azacitidine, for people with advanced or hard-to-treat blood cancers. The first part of the study aims to find the safest and most effective dose. The second part will see how well the drug combination works to …
Matched conditions: RECURRENT MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC